Moderna aims to offset COVID vaccine lawsuit to US govt
10-05-2022
Moderna pledges to not enforce COVID-19 patents in 92 states
08-03-2022
Moderna in dispute with US govt over COVID-19 vaccine inventors
11-11-2021
Ralf Liebhold / Shutterstock.com
Afrigen Biologics has used the publicly available information relating to Moderna’s COVID-19 vaccine to manufacture its own version of the treatment, which could see testing by the end of this year.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Afrigen, South Africa, IP, patents, WHO, Moderna, Pfizer, COVID-19, generics
